Advertisement

Neuroblastoma

  • T. Philip
  • R. Pinkerton
Part of the UICC International Union Against Cancer book series (UICCI)

Abstract

Neuroblastoma is the second most common solid childhood tumor and the outlook for patients with limited disease (25% of the cases) is good. However, with more advanced or metastatic disease, complex and demanding combinations of surgery, chemotherapy, and radiotherapy are required. Even with these treatment modalities the goal of cure remains frustratingly elusive in many patients.

Keywords

Total Body Irradiation Autologous Bone Marrow Transplantation Proc ASCO Dose Melphalan Bone Marrow Rescue 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Rosen EM, Cassady JR, Frantz CN, Kretschmar C, Levey R, Sallan SE (1984) Neuroblastoma: the Joint Center for Radiation Therapy/Dana-Farber Cancer Institute/Children’s Hospital experience. J Clin Oncol 2: 719PubMedGoogle Scholar
  2. 2.
    Le Tourneau JN, Bernard JL, Hendren WH, Carcassonne M (1985) Evaluation of the role of surgery in 130 patients with neuroblastoma. J Pediat Surg 3: 244CrossRefGoogle Scholar
  3. 3.
    Shafford EA, Roger DW, Pritchard J (1984) Advanced neuroblastoma: improved response-rate using a multiagent regimen (OPEC) including sequential cis platinum and VM26. J Clin Oncol 2: 742PubMedGoogle Scholar
  4. 4.
    Carli M, Green AA, Hayes FA, Rivera G, Pratt CB (1982) Therapeutic efficacy of single drugs for childhood neuroblastoma: a review. In: Raybaud C (ed) Proceedings of the XIIIth SIOP Meeting, Marseille. Excerpta Medica, Amsterdam, pp 141–150Google Scholar
  5. 5.
    Hill BT (1986) Neuroblastoma—an overview of laboratory studies aimed at inducing tumor regression by initiation of differentiation or administration of antitumor drugs. Pediatr Hematol Oncol 3: 73PubMedCrossRefGoogle Scholar
  6. 6.
    Philip T, Ghalie R, Pinkerton R, Zucker JM, Bernard JL, Leverger G, Hartmann O (1987) A phase II study of high dose-cis platinum and VP16 in neuroblastoma. J Clin Oncol 5: 941PubMedGoogle Scholar
  7. 7.
    Pinkerton R, Philip T, Bouffet E, Lashford L, Kemshead J (1986) Autologous bone marrow transplantation in paediatric solid tumors. Clin Haematol 15: 187PubMedCrossRefGoogle Scholar
  8. 8.
    Pritchard J, Germond S, Jones D, De Kraker J, Love S (1986) Is high dose melphalan of value in treatment of advanced neuroblastoma? Preliminary results of a randomized trial by the European neuroblastoma study group. Proc ASCO 5: 205Google Scholar
  9. 9.
    Voute PA, Hoefnagel CA, De Kraker J, Marcuse HR (1986) 131I-meta-iodobenzylguanidine (131I-MIBG) as targeted radio-isotope in treatment of children with neuroblastoma. Proc ASCO 5: 213Google Scholar
  10. 10.
    Kemshead JT, Goldman A, Jones D, Pritchard J, Malpas JS, Gordon I, Malone JF, Hurley GD, Breatnach F (1985) Therapeutic application of radiolabelled monoclonal antibody UJ13A in children with disseminated neuroblastoma. A phase 1 study. Adv Neuroblastoma Res 4: 533–544Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • T. Philip
  • R. Pinkerton

There are no affiliations available

Personalised recommendations